A team of researchers in the US, funded by Spinal Research, have made a breakthrough in axon regeneration in an animal model.

The study found that the animals regained complete diaphragm and partial forelimb function on the injured side after treatment with chondroitinase. The recuperative effects of the therapy were fully maintained six months after treatment ended.

Dr Mark Bacon, Spinal Research Executive and Scientific Director said "Spinal Research is immensely proud to have supported this ground-breaking work.  It shows chronic paralysis need not be permanent and gives real hope for those living with paralysis today."

You can read the full story on the Case Western Reserve University website.